ISIN | LU1313772078 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Candriam Sustainable Equity Europe I |
Fund Provider |
CANDRIAM
Serenity, Bloc - B, 19-21, route d'Arlon 8009 Strassen E-Mail: CH@Candriam.com Phone: + 352 2797-1 Web: https://www.candriam.com |
Fund Provider | CANDRIAM |
Representative in Switzerland |
CACEIS Bank, Montrouge, Zurich Branch / Switzerland Zurich Phone: +41 44 405 97 00 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The aim of the Sub-Fund is to enable shareholders to benefit from the growth of the European equity markets with an investment in equities selected by the portfolio management team on a discretionary basis and to outperform the benchmark. The selection is based on the stocks characteristics and growth prospects, as well as proprietary analysis of ESG criteria. |
Peculiarities |
Current Price * | 33.63 EUR | 10.01.2025 |
---|---|---|
Previous Price * | 33.94 EUR | 09.01.2025 |
52 Week High * | 35.44 EUR | 27.09.2024 |
52 Week Low * | 32.02 EUR | 17.01.2024 |
NAV * | 33.63 EUR | 10.01.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 782,280,266 | |
Unit/Share Assets *** | 139,699,139 | |
Trading Information SIX |
YTD Performance | +1.17% |
30.12.2024 - 10.01.2025
30.12.2024 10.01.2025 |
---|---|---|
YTD Performance (in CHF) | +0.89% |
30.12.2024 - 10.01.2025
30.12.2024 10.01.2025 |
1 month | -1.38% |
10.12.2024 - 10.01.2025
10.12.2024 10.01.2025 |
3 months | -2.75% |
10.10.2024 - 10.01.2025
10.10.2024 10.01.2025 |
6 months | -1.49% |
10.07.2024 - 10.01.2025
10.07.2024 10.01.2025 |
1 year | +3.64% |
10.01.2024 - 10.01.2025
10.01.2024 10.01.2025 |
2 years | +6.69% |
10.01.2023 - 10.01.2025
10.01.2023 10.01.2025 |
3 years | +0.48% |
10.01.2022 - 10.01.2025
10.01.2022 10.01.2025 |
5 years | +1.60% |
23.09.2021 - 10.01.2025
23.09.2021 10.01.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
ASML Holding NV | 3.27% | |
---|---|---|
Novo Nordisk AS Class B | 3.05% | |
Novartis AG Registered Shares | 3.03% | |
FinecoBank SpA | 3.02% | |
KBC Groupe NV | 3.00% | |
Roche Holding AG | 2.90% | |
Kerry Group PLC Class A | 2.61% | |
AstraZeneca PLC | 2.52% | |
Nestle SA | 2.38% | |
SAP SE | 2.32% | |
Last data update | 30.11.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.70% |
Ongoing Charges *** | 0.85% |
SRRI ***
|
|
SRRI date *** | 31.12.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |